CATEGORII DOCUMENTE |
Bulgara | Ceha slovaca | Croata | Engleza | Estona | Finlandeza | Franceza |
Germana | Italiana | Letona | Lituaniana | Maghiara | Olandeza | Poloneza |
Sarba | Slovena | Spaniola | Suedeza | Turca | Ucraineana |
DOCUMENTE SIMILARE |
|||
|
|||
Various Types of Headaches
Primary headaches.
Migraine without aura (common migraine). Must have at least 5 attacks that meet
the following criteria:
Headache attacks last 4 to 72 hours.
Headache has at least 2 of the following:
Unilateral location
Pulsating quality
Moderate or severe intensity (inhibits daily activity)
Aggravation by routine physical activity
During the headache, at least 1 of the following:
Nausea or vomiting
Photophobia and phonophobia
No organic cause found by history, PE, neurologic exam.
Migraine with aura (classical migraine). Must have at least 2 attacks
fulfilling the following criteria:
At least 3 of the following are present:
One of more fully reversible aura symptoms indicating focal cerebral cortical
or brainstem dysfunction.
At least one aura symptom develops gradually over more than 4 minutes.
No aura symptom lasts more than 60 minutes (duration proportionally increases
if >1 aura symptom present).
HA follows aura with free interval of less than 60 minutes (may begin before or
with the aura). HA usually lasts 4 to 72 hours but may be absent.
No organic cause found by history, PE, neurologic exam.
Tension type.
Headache with at least 2 of the following:
Pressing or tightening quality
Mild or moderate intensity
Bilateral location
No aggravation by routine physical activity
No organic cause found by history, PE, neurologic exam.
Tension headache is separated into two subtypes based on frequency:
Episodic
Headache lasting 30 minutes to 7 days
No nausea or vomiting with headache
Photophobia and phonophobia are absent, or one but not the other is present
At least 10 previous headaches as above, with number of headache days
<180/year and <15/month
Chronic
Headache averages 15 days/month (180 days/year), 6 months
No vomiting
No more than 1 of the following: nausea, photophobia, or phonophobia
Cluster (episodic or chronic).
Severe unilateral orbital, supraorbital, or temporal pain lasting 15 to 180
minutes untreated.
Headache is associated with at least 1 of the following on the pain side:
Conjunctival injection
Lacrimation
Nasal congestion
Forehead and facial sweating
Rhinorrhea
Miosis
Ptosis
Eyelid edema
Frequency of attacks ranges from 1 to 8 daily.
At least 5 attacks occur as above.
Chronic paroxysmal hemicrania.
Severe unilateral orbital, supraorbital, or temporal pain always on the same
side, lasting 2 to 45 minutes.
Attack frequency >5 a day for more than half the time (periods of lower
frequency may occur).
Headache is associated with at least 1 of the following on the pain side:
Conjunctival injection
Lacrimation
Nasal congestion
Rhinorrhea
Eyelid edema
Ptosis
Absolute effectiveness of indomethacin (150 mg/day or less).
At least 50 attacks occur as above.
No organic cause found by history, PE, neurologic exam.
Secondary headaches.
Increased intracranial pressure (pseudotumor cerebri). Idiopathic, 19 of 100,000
in obese young females. Has been associated with tetracycline use. Often
presents with chronic retrobulbar HA exacerbated by eye movements. Also visual
changes, diplopia, meningeal signs, and paresthesias. Exam may reveal
papilledema and cranial nerve VI palsy. CSF normal except for elevated opening
pressure (250 to 450 mm H2O). Treatment: weight loss, serial LPs to remove 20
to 40 ml, diuretics, acetazolamide 500 to 1000 mg QD, prednisone 40 to 60 mg
QD, and rarely a shunt.
Tumor. HA most common only complaint, though only 50% of tumors present with
HA. 17% have 'typical' tumor HA (worse in morning, nausea, vomiting,
worse bending over). Usually other neurologic signs or symptoms help localize
tumor. Obtain head CT with contrast or MRI for patients with chronic HA
presenting with new symptoms or abnormal neurologic signs. Treatment:
neurosurgical consultation.
Arteritis (giant cell, temporal). Most common symptom is nonspecific headache
often with scalp or temporal artery tenderness. Jaw claudication pathognomic.
Elderly females at increased risk. Sedimentation rate elevated. Biopsy reveals
arteritis. Treatment:
Acute effects of substance use. Occurs within a discrete period after substance
use and disappears with elimination of use.
Substance withdrawal. Occurs after >3 months of high daily dose of
substance. Occurs within hours after elimination and relieved by renewed
intake. Disappears with withdrawal of substance. This includes caffeine use.
Meningitis and herpes encephalitis.
Drug-rebound headache. Aggravating factors: ergotamine induced, analgesic abuse
(such as >50 g/month ASA or equivalent mild analgesic, >300 mg/month
diazepam.) Treatment: stop drug.
Carbon monoxide poisoning.
Subarachnoid hemorrhage (SAH). Generally have acute onset of worst headache of
life. May have nausea, vomiting, mental status changes, or loss of
consciousness. Most (59%) have a 'warning leak' before severe event
and may have antecedent headaches for weeks. Since mortality is 50% for each
bleed, if one can pick up the warning leak, one can prevent death and illness.
May have mental status changes and meningeal signs but may not (39% initially
free of CNS symptoms or signs).
Only 10% have initially focal exam.
May have fever and leukocytosis from meningeal irritation.
CT scan will find only about 90% of SAH (98% in third-generation scanners). All
those who need a CT also need an LP. CT should be done on those with severe
headache that is different from their usual headache or new onset of headache.
In one study, 33% of those with new onset of severe headache and no CNS signs
or symptoms and no other obvious cause of headache had SAH.
Response to nonnarcotic and narcotic analgesia does not rule out SAH.
Nimodipine reduces the risk of cerebral vasospasm, which may contribute to
mortality. Dose is 60 mg Q4h for 21 days.
Physical examination. Vitals (BP and temperature), neurologic deficits,
papilledema, retinal hemorrhage, cranial bruit, thickened tender temporal
arteries, trigger point for fascial pain, ptosis, dilated pupils, and stiff
neck.
Ancillary tests not necessary if physical exam is negative. Routine CT scanning
has low yield except when headaches are severe - an indication that
subarachnoid hemorrhage or a neurologic deficit may be present.
CT should be done to rule out mass lesion.
An LP should be done if CT negative and suspect SAH (CT will miss about 10%).
Be sure to rule out meningitis, temporal arteritis by the clinical setting.
Obtaining a sedimentation rate in elderly patients with new-onset headaches is
prudent.
Remember simple causes such as sinusitis, toothache, temporomandibular joint
syndrome.
Treatment for Migraine Headache
General. Taper off analgesics to prevent rebound HA and start preventive
medications. Depression (if identified) needs to be treated.
Nonpharmacologic prophylaxis for migraine.
Dietary changes.
Avoid monosodium glutamate, nitrates, and alcohol.
Spread out caffeine evenly.
Lifestyle changes. Regular eating, sleeping, and exercise patterns.
Behavioral therapies. Biofeedback, stress management, and self-help groups.
Acute therapy (outpatient).
Acetaminophen or ASA usually are not effective in severe headaches because of
delayed gastric emptying. The uses of metoclopramide 10 mg
NSAIDs. Such as ibuprofen 400 to 800 mg PO TID or QID or naproxen sodium 550 mg
PO BID or TID with food.
Fiorinal 1 or 2 tablets Q4-6h up to 4 per day and twice per week. Avoid
overuse.
Abortive therapy for migraines. Ergotamine derivatives contraindicated in
peripheral or coronary artery disease. Do not use sumatriptan in those who have
had an ergot preparation within the last 24 hours and vice versa.
Midrin 2 caps
Sumatriptan (Imitrex) 6 mg SQ; may repeat in 1 hour; maximum 12 mg/24 hours.
Contraindicated if concomitant CAD or uncontrolled hypertension. Do not use if
patient is given an ergot alkaloid in the last 24 hours. Many (up to 50%) will
require rescue medicine because of sumatriptan's 2-hour halflife. Oral
sumatriptan available but not so effective.
Cafergot 1 or 2 tablets
Ergotamine 2 mg
Prochlorperazine 25 mg PR BID PRN can be used to abort the migraine at home.
Acute therapy (emergency room): migraine.
Antiemetics may in themselves abort the headache.
Prochlorperazine (Compazine) 10 mg IV or chlorpromazine 25 to 75 mg IV.
Chlorpromazine has fallen out of favor because of hypotension, which can be
treated with
Metoclopramide 5 to 10 mg IV Q8h. Often given with dihydroergotamine (DHE) to
prevent DHE-induced nausea. May be combined orally with ASA.
NSAIDs (ketorolac [Toradol] 60 mg IM, indomethacin [Indocin] 50 mg PR BID or
TID). Not so effective in migraines.
Dihydroergotamine (DHE) 0.75 mg IV over a few minutes preceded by
prochlorperazine or metoclopramide 10 mg IV. Another 0.5 mg of DHE may be given
in 30 minutes. Contraindicated in peripheral or coronary artery disease or
those who are >60 years of age or those who have had sumatriptan.
Meperidine (Demerol) 50 to 100 mg IM Q3h PRN.
Dexamethasone 4 mg IM or a short course of prednisone (40 to 60 mg
Sumatriptan (Imitrex); see above for dose. Oral sumatriptan also available but
less effective.
Lidocaine 100 mg IV once for intractable headache. Patient should not drive
after treatment. Risk for seizures, arrhythmia, confusion.
Transnasal butorphanol 1 mg (1 spray in 1 nostril) repeated if necessary in 60
to 90 minutes.
Prophylaxis.
Amitriptyline 10 to 200 mg
Propranolol 20 to 60 mg
Verapamil 40 to 80 mg PO TID (80 to 240 mg/day). Diltiazem and nifedipine are
less effective. More beneficial in migraine with aura or cluster headache.
Trial should be .2 months. Contraindicated in heart failure and heart block.
Constipation is a common side effect.
NSAIDs, especially useful for menstrual migraine.
Cyproheptadine 2 to 4 mg
Methysergide (Sansert) 1 to 2 mg
Ergotamine (low dose) 1 mg
Anticonvulsants.
Carbamazepine 200 to 800 mg
Phenytoin 300 to 800 mg
Valproic acid 250 to 1500 mg
Fluoxetine 10-30 mg
Treatment for Severe Tension Headache
Symptomatic treatment. Simple analgesics, NSAIDs, or TCAs as above.
Preventive treatment. TCAs, beta-blockers, or calcium-channel blockers as
above.
Treatment for Cluster Headache
Acute treatment is by any of the following:
Oxygen inhalation through a nonrebreathing mask at a flow rate of 6 to 8 L/min
for 15 minutes is 70% effective.
Nasal lidocaine 4% solution (15 drops) or 5% ointment (3 swabs) intranasally on
ipsilateral side may be abortive.
Sumatriptan is especially effective for cluster headache because by definition
they last <3 hours. However, this is not an approved usage.
Parenteral therapy as above.
Prophylactic treatment. Low-dose oral ergotamine, methy-sergide, prednisone (60
mg QD for 1 week with a rapid tapering off), verapamil (80 to 160 mg TID),
lithium carbonate 300 mg BID or TID, with or without valproate 250 to 1500 mg
total daily dose divided BID to QID.
Rates of successfuln
pregnancy following 3 spontaneous losses(habitual abortions) are
a. very poor
b. slightly worse than those in the baseline population
c. No different from those in the baseline population
d. just under 50%
e. good unless cervical incompetenence is diagonosed
Give explanation
E
The data applies to
cases of rec abortion without identifiable causes.
if 3 preg lost- 70-80% success
if 4/5 preg lost- 65-70% success.
Hope this helps.
DURING PREGNENCY OR
LACTATION, WHAT HAPPENS TO BREAST CANCER OCCURING RATE:
A INCREASE
B DECREASE
C REMAINS THE SAME
PLEASE ANSWER WHY DURING PREGNENCY OR LACTATION, WHAT HAPPENS TO BREAST CANCER
OCCURING RATE:
A INCREASE
B DECREASE
C REMAINS THE SAME
PLEASE ANSWER WHY
Pregnancy MAY
accelerate the growth of CA Breast- inflammatory CA is infact most common in
lactating mothers.
Prepregnancy mammography is advised in women>35 expecting
No effect of cyclic
hormones during this period
example:
lactation decreases breast cancer risk
Have more kids to reduce your risk of breast & uterine Cancer
Nulliparous women more risk of having cancer
Politica de confidentialitate | Termeni si conditii de utilizare |
Vizualizari: 943
Importanta:
Termeni si conditii de utilizare | Contact
© SCRIGROUP 2024 . All rights reserved